Nifty
Sensex
:
:
25069.20
81785.74
-44.80 (-0.18%)
-118.96 (-0.15%)

Pharmaceuticals & Drugs

Rating :
45/99

BSE: 500259 | NSE: LYKALABS

98.11
15-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  100.95
  •  100.95
  •  96.71
  •  99.33
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  73580
  •  7244254.51
  •  176.59
  •  96.71

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 350.58
  • 46.68
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 387.23
  • N/A
  • 3.35

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 58.16%
  • 5.25%
  • 31.41%
  • FII
  • DII
  • Others
  • 0.16%
  • 0.29%
  • 4.73%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.60
  • 9.94
  • 14.17

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.16
  • -1.83
  • 1.27

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.06
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.57
  • 10.06
  • 14.58

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 100.35
  • 19.17
  • 23.22

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
33.02
30.11
9.66%
33.43
27.77
20.38%
33.80
32.56
3.81%
41.16
27.99
47.05%
Expenses
29.34
26.41
11.09%
29.34
25.74
13.99%
28.60
25.70
11.28%
36.20
23.81
52.04%
EBITDA
3.69
3.71
-0.54%
4.08
2.03
100.99%
5.19
6.86
-24.34%
4.95
4.18
18.42%
EBIDTM
11.16%
12.31%
12.22%
7.31%
15.37%
21.08%
12.03%
14.94%
Other Income
0.63
0.56
12.50%
0.82
0.29
182.76%
0.83
0.54
53.70%
0.03
0.25
-88.00%
Interest
0.85
0.65
30.77%
0.47
1.07
-56.07%
0.61
1.28
-52.34%
0.54
1.19
-54.62%
Depreciation
2.11
1.76
19.89%
1.42
2.90
-51.03%
1.83
2.84
-35.56%
1.76
3.60
-51.11%
PBT
1.35
1.86
-27.42%
3.02
-1.63
-
3.57
3.29
8.51%
2.67
-0.79
-
Tax
0.36
0.57
-36.84%
0.99
0.46
115.22%
0.87
1.27
-31.50%
0.76
-0.18
-
PAT
1.00
1.29
-22.48%
2.03
-2.09
-
2.71
2.01
34.83%
1.91
-0.62
-
PATM
3.02%
4.28%
6.07%
-7.52%
8.00%
6.18%
4.65%
-2.20%
EPS
0.26
0.40
-35.00%
0.50
-0.60
-
0.76
0.54
40.74%
0.59
-0.15
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
141.41
138.50
111.19
93.07
194.08
86.25
61.49
70.78
59.81
110.08
130.41
Net Sales Growth
19.40%
24.56%
19.47%
-52.05%
125.02%
40.27%
-13.13%
18.34%
-45.67%
-15.59%
 
Cost Of Goods Sold
56.83
55.59
44.85
37.55
52.97
37.97
35.79
39.25
29.38
53.85
70.43
Gross Profit
84.58
82.90
66.34
55.52
141.11
48.28
25.70
31.54
30.43
56.23
59.98
GP Margin
59.81%
59.86%
59.66%
59.65%
72.71%
55.98%
41.80%
44.56%
50.88%
51.08%
45.99%
Total Expenditure
123.48
120.56
95.49
76.23
92.94
66.57
65.16
72.68
63.36
87.31
110.25
Power & Fuel Cost
-
3.90
3.93
3.60
3.92
2.94
2.56
2.28
1.86
1.90
1.39
% Of Sales
-
2.82%
3.53%
3.87%
2.02%
3.41%
4.16%
3.22%
3.11%
1.73%
1.07%
Employee Cost
-
34.63
26.77
18.61
18.06
14.57
13.86
14.69
16.98
17.24
14.71
% Of Sales
-
25.00%
24.08%
20.00%
9.31%
16.89%
22.54%
20.75%
28.39%
15.66%
11.28%
Manufacturing Exp.
-
5.22
4.52
5.09
4.20
3.00
1.73
1.32
1.06
1.20
1.24
% Of Sales
-
3.77%
4.07%
5.47%
2.16%
3.48%
2.81%
1.86%
1.77%
1.09%
0.95%
General & Admin Exp.
-
11.23
9.32
7.89
6.29
4.31
5.70
5.91
5.81
5.96
6.62
% Of Sales
-
8.11%
8.38%
8.48%
3.24%
5.00%
9.27%
8.35%
9.71%
5.41%
5.08%
Selling & Distn. Exp.
-
8.43
4.70
2.59
5.75
2.65
2.27
5.17
2.95
0.37
8.61
% Of Sales
-
6.09%
4.23%
2.78%
2.96%
3.07%
3.69%
7.30%
4.93%
0.34%
6.60%
Miscellaneous Exp.
-
1.55
1.41
0.90
1.74
1.14
3.24
4.07
5.31
6.80
8.61
% Of Sales
-
1.12%
1.27%
0.97%
0.90%
1.32%
5.27%
5.75%
8.88%
6.18%
5.56%
EBITDA
17.91
17.94
15.70
16.84
101.14
19.68
-3.67
-1.90
-3.55
22.77
20.16
EBITDA Margin
12.67%
12.95%
14.12%
18.09%
52.11%
22.82%
-5.97%
-2.68%
-5.94%
20.68%
15.46%
Other Income
2.31
2.23
1.46
3.40
2.09
1.56
3.09
2.09
2.13
2.24
2.06
Interest
2.47
2.27
4.89
11.87
20.13
25.94
20.07
7.17
9.58
18.72
16.42
Depreciation
7.12
6.77
12.80
14.15
17.35
8.32
8.01
7.31
11.28
10.25
9.32
PBT
10.61
11.12
-0.52
-5.78
65.77
-13.02
-28.66
-14.29
-22.28
-3.97
-3.52
Tax
2.98
3.19
1.69
-0.02
20.80
-4.05
0.74
-9.07
-1.04
-1.51
-0.19
Tax Rate
28.09%
28.69%
-181.72%
0.15%
35.11%
28.62%
-1.20%
58.78%
5.19%
18.62%
-4.86%
PAT
7.65
8.01
-2.49
-13.21
39.00
-11.55
-60.54
-5.55
-17.21
-5.54
3.69
PAT before Minority Interest
7.52
7.93
-2.62
-13.15
38.44
-10.09
-62.62
-6.35
-19.00
-6.60
4.09
Minority Interest
-0.13
0.08
0.13
-0.06
0.56
-1.46
2.08
0.80
1.79
1.06
-0.40
PAT Margin
5.41%
5.78%
-2.24%
-14.19%
20.09%
-13.39%
-98.46%
-7.84%
-28.77%
-5.03%
2.83%
PAT Growth
1,196.61%
-
-
-
-
-
-
-
-
-
 
EPS
2.14
2.24
-0.70
-3.70
10.92
-3.24
-16.96
-1.55
-4.82
-1.55
1.03

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
103.55
68.15
45.44
13.34
-25.80
-14.34
43.02
49.47
37.71
45.24
Share Capital
35.69
33.09
30.69
28.69
28.69
28.69
28.14
28.14
22.04
23.13
Total Reserves
67.86
26.00
-2.69
-15.35
-54.49
-43.03
14.12
20.57
15.67
22.11
Non-Current Liabilities
25.99
50.82
73.25
72.77
148.88
136.67
72.28
5.28
38.68
28.52
Secured Loans
9.72
7.18
0.39
0.86
150.65
125.45
78.39
4.06
34.93
25.31
Unsecured Loans
9.48
35.73
63.40
61.63
0.71
0.64
0.90
0.87
0.84
0.00
Long Term Provisions
0.65
1.82
2.44
3.47
3.66
3.86
4.08
3.63
4.39
2.92
Current Liabilities
46.63
37.77
32.60
99.35
49.88
66.32
84.81
167.12
165.45
162.83
Trade Payables
14.95
12.10
9.41
12.00
14.71
18.85
23.23
24.21
39.16
42.08
Other Current Liabilities
15.28
12.41
14.35
66.24
23.10
30.83
43.31
92.38
73.07
56.55
Short Term Borrowings
14.83
11.61
7.64
20.07
10.37
14.41
16.26
45.82
50.23
59.95
Short Term Provisions
1.57
1.65
1.20
1.05
1.70
2.23
2.02
4.72
2.99
4.26
Total Liabilities
176.20
156.85
151.52
185.61
173.66
187.88
202.85
225.23
248.87
240.50
Net Block
85.11
57.70
68.10
93.96
98.19
104.78
107.73
116.04
132.90
104.23
Gross Block
191.40
157.75
157.96
177.35
202.50
188.36
202.81
155.31
144.01
200.41
Accumulated Depreciation
106.29
100.05
89.87
83.40
104.31
83.58
95.08
39.27
11.11
96.18
Non Current Assets
108.77
106.20
107.32
133.42
144.59
152.00
167.75
176.16
186.07
158.70
Capital Work in Progress
1.20
23.05
16.23
17.74
25.76
27.76
31.07
27.88
24.23
30.17
Non Current Investment
0.02
0.07
0.04
0.01
0.01
0.01
0.01
0.23
0.26
0.39
Long Term Loans & Adv.
22.43
25.38
22.96
21.71
20.63
19.46
28.94
32.01
28.69
23.92
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
67.43
50.65
44.20
52.20
29.08
35.88
35.11
49.07
62.79
81.81
Current Investments
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
Inventories
12.47
9.57
6.95
8.20
4.31
6.73
7.00
11.20
13.24
10.81
Sundry Debtors
43.08
26.99
20.13
18.45
8.67
8.04
14.63
20.50
29.17
43.29
Cash & Bank
1.34
5.95
11.71
17.05
7.15
10.30
1.71
2.43
5.12
5.56
Other Current Assets
10.52
3.34
2.93
2.87
8.94
10.80
11.77
14.95
15.25
22.14
Short Term Loans & Adv.
4.05
4.78
2.48
5.62
4.21
4.26
9.64
13.21
10.92
17.22
Net Current Assets
20.80
12.88
11.61
-47.15
-20.80
-30.44
-49.70
-118.05
-102.66
-81.03
Total Assets
176.20
156.85
151.52
185.62
173.67
187.88
202.86
225.23
248.86
240.51

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
1.90
1.77
8.95
79.25
8.81
5.32
26.67
10.88
31.38
11.95
PBT
11.12
-0.93
-13.17
59.25
-14.14
-61.88
-15.42
-20.04
-8.10
3.69
Adjustment
8.46
18.02
31.78
41.93
35.40
55.76
15.17
20.79
30.53
16.15
Changes in Working Capital
-14.65
-13.80
-9.86
-21.01
-11.64
10.94
27.65
10.36
10.10
-7.57
Cash after chg. in Working capital
4.93
3.29
8.75
80.16
9.62
4.82
27.39
11.10
32.53
12.27
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.03
-1.52
0.20
-0.92
-0.81
0.50
-1.10
-0.44
-1.20
-0.33
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.37
0.23
0.06
0.00
Cash From Investing Activity
-11.80
-9.49
7.35
-6.17
-0.16
-0.11
-3.97
-3.17
-12.67
17.29
Net Fixed Assets
-13.40
-6.61
19.80
-2.28
-20.42
-43.81
-2.41
-3.63
12.94
-4.69
Net Investments
0.00
-0.01
0.00
0.00
0.00
30.05
-0.01
0.00
0.12
0.00
Others
1.60
-2.87
-12.45
-3.89
20.26
13.65
-1.55
0.46
-25.73
21.98
Cash from Financing Activity
5.29
1.95
-21.64
-63.18
-11.80
3.38
-23.42
-10.41
-19.15
-30.19
Net Cash Inflow / Outflow
-4.60
-5.76
-5.34
9.90
-3.15
8.60
-0.72
-2.69
-0.43
-0.96
Opening Cash & Equivalents
5.95
11.71
17.05
7.15
10.30
1.71
2.43
5.12
5.56
6.51
Closing Cash & Equivalent
1.34
5.95
11.71
17.05
7.15
10.30
1.70
2.43
5.12
5.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
29.01
17.86
9.12
4.65
-8.99
-5.00
15.02
16.78
15.82
16.94
ROA
4.76%
-1.70%
-7.80%
21.40%
-5.58%
-32.05%
-2.97%
-8.02%
-2.70%
1.58%
ROE
9.76%
-6.02%
-63.63%
0.00%
0.00%
-448.65%
-14.20%
-46.30%
-18.27%
11.74%
ROCE
10.06%
3.26%
-1.00%
56.68%
8.95%
-31.39%
-5.50%
-6.52%
6.66%
12.41%
Fixed Asset Turnover
0.79
0.70
0.56
1.02
0.44
0.31
0.40
0.41
0.68
0.65
Receivable days
92.33
77.33
75.65
25.51
35.37
67.29
90.56
149.54
113.31
136.29
Inventory Days
29.04
27.12
29.71
11.76
23.36
40.77
46.92
73.58
37.61
40.97
Payable days
88.82
87.52
104.00
92.01
161.35
117.58
127.84
181.43
174.53
168.94
Cash Conversion Cycle
32.55
16.94
1.36
-54.74
-102.62
-9.53
9.65
41.69
-23.60
8.32
Total Debt/Equity
0.37
0.96
2.58
9.76
-6.30
-9.85
2.28
2.39
3.60
3.12
Interest Cover
5.90
0.81
-0.11
3.94
0.45
-2.08
-1.15
-1.09
0.57
1.24

News Update:


  • Lyka Labs - Quarterly Results
    1st Aug 2025, 12:50 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.